Affective Disorder
12
1
3
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 12 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (12)
The Effect of IPS-MA- A Modified Early Supported Employment Intervention for Individuals With Mood or Anxiety Disorders
Validation of the French Version of the Perinatal Assessment of Paternal Affectivity (PAPA)
Value of Gym-based Exercise Training for Young Adults Receiving Antipsychotic Medication: The Vega Trial
Better Sleep in Psychiatric Care - Depression, Anxiety and PTSD
Naturalistic Study of Ketamine in the Treatment of Depression
Physical Activity, Psychopathology, and Quality of Life in People With Psychotic or Affective Disorders
New Techniques for Diagnosis and Treatment of Cognitive Impairment in Affective Disorder
Towards Neurobiology-based Diagnosis and Treatment of Affective Disorders
Brief Group Psychotherapy for Anxiety and Depression
Patient-controlled Admissions in Inpatient Mental Health Services
Copeptin in Outcome Prediction of an Acute Psychotic Episode
Effectiveness of a Cognitive Remediation Intervention Based on Virtual Reality for Promotion of Cognitive Functioning and Participation in Daily Life Among Persons With Affective Disorder